Recursion Pharmaceuticals
RXRX
#5242
Rank
A$2.50 B
Marketcap
A$4.67
Share price
-0.59%
Change (1 day)
-34.38%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: A$2.50 Billion

As of September 2026 Recursion Pharmaceuticals has a market cap of A$2.50 Billion. This makes Recursion Pharmaceuticals the world's 5242th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.50 B-24.25%
2025A$3.30 B-28.75%
2024A$4.64 B48.59%
2023A$3.12 B45.47%
2022A$2.14 B-46.21%
2021A$3.99 B

End of Day market cap according to different sources

On Sep 2nd, 2026 the market cap of Recursion Pharmaceuticals was reported to be:

A$2.51 Billion
by Nasdaq info icon info icon
A$2.52 Billion
by CompaniesMarketCap info icon info icon